Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1380751 | 0.85 | CASP1 (0.44) | MAOAMAOBCYP2A6CASP1CASP7 | |
| SCHEMBL1891844 | 0.82 | MAOA (0.53) | MAOAMAOBCYP2A6PRKCIHSD17B1 | |
| SCHEMBL22367713 | 0.75 | — | — | |
| SCHEMBL134194 | 0.74 | — | — | |
| SCHEMBL1451149 | 0.70 | PBRM1 (0.44) | MAOAMAOBCYP2A6CASP1CASP7 | |
| SCHEMBL11849586 | 0.69 | MAOB (0.68) | MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL5203864 | 0.69 | MAOB (0.69) | MAOAMAOBCASP1CASP7HSD17B10 | |
| SCHEMBL7974509 | 0.69 | CASP1 (0.44) | MAOAMAOBCYP2A6CASP1CASP7 | |
| SCHEMBL23277084 | 0.69 | PBRM1 (0.33) | MAOAMAOBCYP2A6CASP1CASP7 | |
| SCHEMBL8162675 | 0.68 | CES1 (0.61) | MAOAMAOBCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017681-B1 | HYDRAZONO-BENZAZULENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATES | AVENTIS PHARMA SA (FR) | 2003-04-09 | — | — | EP | disclosed |
| EP-0888292-A1 | TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY $g(a)v$g(b)3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | HOECHST MARION ROUSSEL (FR) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034865-A1 | TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY αvβ3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | HOECHST MARION ROUSSEL (FR) | 1997-09-25 | — | — | WO | disclosed |